Health Canada
- Status: approved
🇨🇦 Empagliflozin and Linagliptin in Canada
Empagliflozin and Linagliptin (Empagliflozin and Linagliptin) regulatory status in Canada.
Marketing authorisation
Empagliflozin and Linagliptin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Empagliflozin and Linagliptin approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Empagliflozin and Linagliptin in Canada?
Institut für Pharmakologie und Präventive Medizin is the originator. The local marketing authorisation holder may differ — check the official source linked above.